Virgin Herbert's Form 4 filing
Vir Biotechnology, Inc. (VIR) · filed Sep 9, 2021
- Accession no.
- 0001209191-21-055311
- Filed
- Sep 9, 2021
- Trade date
- Sep 7, 2021
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Not on the form (before 2023)
This filing lists 3 non-derivative transactions and 1 derivative transaction. Open-market sales total $204.9K. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Virgin HerbertCIK 0001786378 | Officer (EVP, Research & CSO) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Sep 7, 2021 | Common Stock | MOption exerciseAcquired | +4,125 | $1.53 | +$6,311.25 | 103,825 | Direct | |
| Sep 7, 2021 | Common Stock | SSaleDisposed | −1,375 | $49.00 | −$67,375 | 102,450 | Direct | |
| Sep 7, 2021 | Common Stock | SSaleDisposed | −2,750 | $50.00 | −$137,500 | 99,700 | Direct |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Sep 7, 2021 | Common Stock | MOption exerciseDisposed | −4,125 | $0.00 | $0 | 263,255 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
No transaction price on this filing refers to a footnote.